DNA GTx

PIK3CA Mutation Test

Home > RT-PCR > PIK3CA Mutation Test

Clinically Relevant Mutation Detection

Targeted PIK3CA Testing for Personalized Breast & Colon Cancer Care

DNA GTx’s PIK3CA Test detects five clinically significant mutations in the PIK3CA gene, known to play a key role in the development and progression of various cancers, including breast and colorectal cancers. Identifying these somatic mutations can guide treatment selection, particularly the use of PIK3CA-targeted therapies, and support informed, personalized care planning.

Who is this Test for?

What it Screens for

Key Benefits

Turn Around Time

Do You Need a Doctor’s Request?

Yes. A healthcare provider must request this test to ensure proper interpretation and use of the results in your care.

How it Works?

Let’s Decode the Future of Health — Together

Get in touch today — let’s start a conversation that could change lives

*All information is handled with strict confidentiality.

Find Answers Today

Early detection saves lives

*All information is handled with strict confidentiality.

Blogs